1. Home
  2. AXNX

AXNX

Axonics Inc.

Logo Axonics Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

Founded: N/A Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 3.4B IPO Year: N/A
Target Price: $71.25 AVG Volume (30 days): 943.5K
Analyst Decision: Hold Number of Analysts: 11
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.12 EPS Growth: N/A
52 Week Low/High: $47.59 - $69.68 Next Earning Date: 05-03-2024
Revenue: $366,379,000 Revenue Growth: 33.86%
Revenue Growth (this year): 24.7% Revenue Growth (next year): 20.18%

Share on Social Networks: